AquaBounty Technologies I...
0.77
0.03 (4.03%)
At close: Jan 14, 2025, 3:59 PM
0.72
-5.98%
Pre-market Jan 15, 2025, 06:58 AM EST
undefined%
Bid 0.71
Market Cap 2.97M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -19.06
PE Ratio (ttm) -0.04
Forward PE n/a
Analyst Hold
Ask 0.77
Volume 119,438
Avg. Volume (20D) 454,790
Open 0.77
Previous Close 0.74
Day's Range 0.72 - 0.78
52-Week Range 0.47 - 2.79
Beta undefined

About AQB

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aq...

IPO Date Jan 11, 2017
Employees 104
Stock Exchange NASDAQ
Ticker Symbol AQB

Analyst Forecast

According to 2 analyst ratings, the average rating for AQB stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 0.00%
Hold 50.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

AquaBounty Technologies Inc. is scheduled to release its earnings on Mar 31, 2025, before market opens.
Analysts project revenue of $200.00K, reflecting a -63.85% YoY shrinking and earnings per share of -0.62, making a -71.69% decrease YoY.
1 month ago · Source
-23.22%
AquaBounty Technologies shares are trading lower a... Unlock content with Pro Subscription
5 months ago · Source
-16.27%
AquaBounty Technologies shares are trading lower after the company reported a year-over-year decrease in Q2 EPS results.